Background In economic analyses of HIV interventions, South Africa is often used as a case
in point, due to the availability of good epidemiological and programme data and the global …

Policy discussions about the feasibility of massively scaling up antiretroviral therapy (ART) to
reduce HIV transmission and incidence hinge on accurately projecting the cost of such scale …

Background Antiretroviral Treatment (ART) significantly reduces HIV transmission. We
conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa …

Introduction Nearly 220000 patients are diagnosed with end-stage renal disease (ESRD)
every year, which calls for an additional demand of 34 million dialysis sessions in India. The …

Introduction To achieve universal health coverage, the Government of India has introduced
Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), a large tax-funded …

Background The rapid decrease in international funding for HIV/AIDS has been challenging
for many nations to effectively mobilize and allocate their limited resources for HIV/AIDS …

Introduction After almost 10 years of PEPFAR funding for antiretroviral therapy (ART)
treatment programmes in Kenya, little is known about the cost of care provided to HIV …

The substitution by generic equivalents of some of the drugs included in fixed-dose
antiretroviral coformulations (FDACs) poses the potential risk of disrupting these …

As antiretroviral treatment (ART) for HIV/AIDS is scaled up globally, information on per-
person costs is critical to improve efficiency in service delivery and to maximize coverage …

Introduction Although HIV infection and its associated co-morbidities remain the commonest
reason for hospitalisation in Africa, their impact on economic costs and health-related quality …